Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Essentials for clinicians: head and neck tumours and neuro-oncology.

Le Rhun E.

ESMO Open. 2017 Feb 20;1(6):e000156. doi: 10.1136/esmoopen-2016-000156. eCollection 2016. No abstract available.

2.

Temozolomide and Bevacizumab Induction before Chemoradiotherapy in Patients with Bulky Glioblastoma and/or with Severe Neurological Impairment.

Darmon I, Morisse MC, Coutte A, Blonski M, Le Rhun E, Taillandier L, Roufai DB, Desenclos C, Trudel S, Faivre JC, Blanchard N, Chauffert B, Boone M.

J Cancer. 2017 May 12;8(8):1417-1424. doi: 10.7150/jca.18339. eCollection 2017.

3.

Increased risk of brain metastases in women with breast cancer and p16 expression in metastatic lymph-nodes.

Furet E, El Bouchtaoui M, Feugeas JP, Miquel C, Leboeuf C, Beytout C, Bertheau P, Le Rhun E, Bonneterre J, Janin A, Bousquet G.

Oncotarget. 2017 Jun 6;8(23):37332-37341. doi: 10.18632/oncotarget.16953.

4.

Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningioma.

Furtner J, Schöpf V, Seystahl K, Le Rhun E, Rudà R, Roelcke U, Koeppen S, Berghoff AS, Marosi C, Clement P, Faedi M, Watts C, Wick W, Soffietti R, Weller M, Preusser M.

Neuro Oncol. 2016 Mar;18(3):401-7. doi: 10.1093/neuonc/nov183. Epub 2015 Sep 9.

5.

Immunotherapy with CpG-ODN in neoplastic meningitis: A phase I trial.

Ursu R, Taillibert S, Banissi C, Vicaut E, Bailon O, Le Rhun E, Guillamo JS, Psimaras D, Tibi A, Sacko A, Marantidou A, Belin C, Carpentier AF.

Cancer Sci. 2015 Sep;106(9):1212-8. doi: 10.1111/cas.12724. Epub 2015 Jul 29.

6.

Prolonged Response and Restoration of Functional Independence with Bevacizumab plus Vinorelbine as Third-Line Treatment for Breast Cancer-Related Leptomeningeal Metastases.

Le Rhun E, Taillibert S, Boulanger T, Zairi F, Bonneterre J, Chamberlain MC.

Case Rep Oncol. 2015 Feb 12;8(1):72-7. doi: 10.1159/000375293. eCollection 2015 Jan-Apr.

7.

The future of high-grade glioma: Where we are and where are we going.

Le Rhun E, Taillibert S, Chamberlain MC.

Surg Neurol Int. 2015 Feb 13;6(Suppl 1):S9-S44. doi: 10.4103/2152-7806.151331. eCollection 2015. Erratum in: Surg Neurol Int. 2015 Mar 5;6:37. Rhun, Emilie Le [corrected to Le Rhun, Emilie].

8.

Brain Metastases of Her2-Positive Breast Cancer: A Case of 34 Months' Remission with Lapatinib plus Capecitabine.

Mailliez A, Servent V, Bonneterre J, Le Rhun E.

Case Rep Oncol. 2014 Aug 7;7(2):555-9. doi: 10.1159/000365747. eCollection 2014 May.

9.

Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials.

Chamberlain M, Soffietti R, Raizer J, Rudà R, Brandsma D, Boogerd W, Taillibert S, Groves MD, Le Rhun E, Junck L, van den Bent M, Wen PY, Jaeckle KA.

Neuro Oncol. 2014 Sep;16(9):1176-85. doi: 10.1093/neuonc/nou089. Epub 2014 May 27. Review.

10.

Rationale for the use of upfront whole brain irradiation in patients with brain metastases from breast cancer.

Tallet AV, Azria D, Le Rhun E, Barlesi F, Carpentier AF, Gonçalves A, Taillibert S, Dhermain F, Spano JP, Metellus P.

Int J Mol Sci. 2014 May 8;15(5):8138-52. doi: 10.3390/ijms15058138. Review.

11.

Treatment patterns, clinical outcomes and health care costs associated with HER2-positive breast cancer with central nervous system metastases: a French multicentre observational study.

Baffert S, Cottu P, Kirova YM, Mercier F, Simondi C, Bachelot T, Le Rhun E, Levy C, Gutierrez M, Madranges N, Moldovan C, Coudert B, Spaëth D, Serin D, Cotté FE, Benjamin L, Maillard C, Laulhere-Vigneau S, Durand-Zaleski I.

BMC Health Serv Res. 2013 Oct 31;13:456. doi: 10.1186/1472-6963-13-456.

12.

Memory loss during lenalidomide treatment: a report on two cases.

Rollin-Sillaire A, Delbeuck X, Pollet M, Mackowiak MA, Lenfant P, Noel MP, Facon T, Leleu X, Pasquier F, Le Rhun E.

BMC Pharmacol Toxicol. 2013 Aug 12;14:41. doi: 10.1186/2050-6511-14-41.

13.

Carcinomatous meningitis: Leptomeningeal metastases in solid tumors.

Le Rhun E, Taillibert S, Chamberlain MC.

Surg Neurol Int. 2013 May 2;4(Suppl 4):S265-88. doi: 10.4103/2152-7806.111304. Print 2013.

14.

Development of a new method for identification and quantification in cerebrospinal fluid of malignant cells from breast carcinoma leptomeningeal metastasis.

Le Rhun E, Massin F, Tu Q, Bonneterre J, Bittencourt Mde C, Faure GC.

BMC Clin Pathol. 2012 Nov 12;12:21. doi: 10.1186/1472-6890-12-21.

15.

Translation initiator EIF4G1 mutations in familial Parkinson disease.

Chartier-Harlin MC, Dachsel JC, Vilariño-Güell C, Lincoln SJ, Leprêtre F, Hulihan MM, Kachergus J, Milnerwood AJ, Tapia L, Song MS, Le Rhun E, Mutez E, Larvor L, Duflot A, Vanbesien-Mailliot C, Kreisler A, Ross OA, Nishioka K, Soto-Ortolaza AI, Cobb SA, Melrose HL, Behrouz B, Keeling BH, Bacon JA, Hentati E, Williams L, Yanagiya A, Sonenberg N, Lockhart PJ, Zubair AC, Uitti RJ, Aasly JO, Krygowska-Wajs A, Opala G, Wszolek ZK, Frigerio R, Maraganore DM, Gosal D, Lynch T, Hutchinson M, Bentivoglio AR, Valente EM, Nichols WC, Pankratz N, Foroud T, Gibson RA, Hentati F, Dickson DW, Destée A, Farrer MJ.

Am J Hum Genet. 2011 Sep 9;89(3):398-406. doi: 10.1016/j.ajhg.2011.08.009.

Supplemental Content

Loading ...
Support Center